Clinical Trial Search

Primary: Number of Major Adverse Cardiac Events (MACE) — 9; 6; 2; 119 Participants

Primary: Primary Composite Outcome: Death From Cardiovascular Causes, Myocardial Infarction, or Hospitalization for Unstable Angina, Heart Failure, or Resuscitated Cardiac Arrest…

Primary: Incidence of Death From Any Cause or Myocardial Infarction — 123; 129 Participants

Primary: Diagnosis of IHD at Invasive Coronary Angiography and FFR Measurement — 140 participants

Primary: Myocardial Perfusion Reserve — 2.76; 2.47; 2.82; 2.52 Ratio

Primary: Anginal Frequency — 86.67; 74.44 units on a scale — p=0.058

Primary: Magnetic Resonance Image Quality Rating — 3.57; 2.55 units on a likert scale — p=<0.001

Primary: Degree of Left Ventricular Remodeling, as Assessed by Left Ventricular End Systolic Volume Index (LVESVI) — 54.6; 60.7 ml per square meter of body-surface area — p=0.18

Primary: Percent Agreement Between Coronary Calcium Score (CCS) and National Cholesterol Education Program (NCEP) Guidelines — 18 percent agreement

Primary: Change in Post-exercise Coronary Vasodilator Reserve — -4; 2 % change

Primary: To Determine Platelet Inhibition Before and After Switching for Two Weeks From Clopidogrel to Ticagrelor in Patients With CLI. — 173; 140; 71; 63 P2Y12 reaction units…

Primary: Percentage of Participants With an Absence of Mental Stress-induced Myocardial Ischemia (MSIMI) During the 3 Mental Stressors — 34.2; 17.5 percentage of participants

Primary: Number of Angina Episodes Per Week at 6 and 12 Months — 6.8; 8.3; 10.9; 6.3 angina episodes/week — p=0.020

Primary: Number of Participants That Had First Occurrence of the Composite Endpoint — 32; 40 Participants

Primary: Kaplan-Meier Estimates for Time From Randomization to First Occurrence of Ischemia-driven Revascularization or Ischemia-driven Hospitalization Without Revascularization…

Primary: Participants Stopping Exercise Treadmill Test 3 (ETT-3) for Angina at Stage Earlier Than Baseline Exercise Treadmill Test (ETT-B) — 0; 0; 1 Participants

Primary: Number of Myocardial Ischemia Attacks in 24 Hours — 2.3; 3.8 ischemic attacks per 24 hours — p=<0.0001

Primary: Myeloperoxidase — 184.3; 66.5; 144.71 g/L

Primary: Quantification of Myocardial Blood Volume — 3.63; 1.23 seconds^-1

Primary: Comparison Between Coronary-artery-disease Group and Non-coronary-artery-disease Group on MIF Concentration — 48.08; 66.79 MIF Concentration,ug/L

Primary: State Hopelessness — 1.25 units on a scale — p=<0.05

Primary: Number of Flow-limiting Coronary Artery Stenosis on CT — 8 Coronary arteries

Primary: Ejection Fraction — 33; 30; 25 % of blood ejected with each beat

Primary: Change in Maximal Oxygen Consumption (VO2max) — -0.6; 0.4 mL/kg/min — p=0.169

Primary: Change From Baseline in % Flow Mediated Dilatation (FMD) — 0.09; 0.32 %FMD

Primary: Average Peak Velocity (APV) Immediately Following Percutaneous Coronary Intervention (PCI) — 30; 19 cm/s — p=0.029

Primary: Participation in Cardiac Rehabilitation — 231; 252 Participants — p=0.80

Primary: All-cause Death or Subsequent Non-fatal Type 1 or Type 4b MI at One Year Measured as Time to First Such Event. — 51; 53 Participants

Primary: Maximum Increase of Troponin at 24 Hours — 0.478; 0.476 ng/ml

Primary: Myocyte Lipid Accumulation as Oil Red-O Positive Biopsie — 54; 21; 0 Endomyocardial Biopsies